Oregon Health & Science University and Intel have added two new participants to its Collaborative Cancer Cloud to include two other leading cancer research institutions – Dana-Farber Cancer Institute in Boston and Ontario Institute for Cancer Research in Toronto.
Dana-Farber has one of the world’s largest databases of genetic abnormalities driving cancer. While Ontario Institute for Cancer Research is an innovative translational research institute dedicated to research on the prevention, early detection, diagnosis and treatment of cancer.
OHSU Knight Cancer Institute and Intel have collaborated for the past three years. The entities always wanted to make the Cancer Cloud nonproprietary — an open ecosystem so that researchers around the world can use the data and connect with one another.
The distributed cloud platform is designed to scale to massive amounts of data and aggregated computation, leveraging Intel’s technology. Institutions won’t lose control of their own datasets or any intellectual property that results.
The Cancer Cloud marks a major advance in precision medicine, in which therapies are customized to individuals but rely on vast stores of data that must be crunched quickly. Intel and OHSU want to make precision medicine possible ”all in a day” for less than $1,000 by 2020.